drugset / Trial / NCT02832570

Sildenafil Efficacy Study on Time Walk From Peripheral Arterial Desease Patients (Stade II) With Arterial Claudication

NCT02832570

Phase 3 Completed 14 enrolled University Hospital, Angers
RandomizedCrossoverQuadruple-blindTreatment

Summary

Efffect of a single dose oral intake of sildenafil Or placebo on the walking capacity on treadmill of PAD patients with claudication

Timeline

Start
2016-11-07
Primary completion
2017-10
Completion
2017-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 100 mg Oral